Issue 16, 2025

ROS-responsive poly(β-amino ester) nanoparticles enable targeted delivery of mRNA vaccine to splenic antigen-presenting cells

Abstract

Intravenous mRNA vaccines show promise for stimulating immune cells but face challenges in targeting APCs due to high liver accumulation. To address this, we developed ROS-responsive PBAE nanoparticles, 93-TKA10-19, designed to target splenic APCs, enhance mRNA expression, and induce a Th1-skewed immune response, advancing mRNA vaccine efficacy.

Graphical abstract: ROS-responsive poly(β-amino ester) nanoparticles enable targeted delivery of mRNA vaccine to splenic antigen-presenting cells

Supplementary files

Article information

Article type
Communication
Submitted
14 Nov 2024
Accepted
27 Jan 2025
First published
27 Jan 2025

Chem. Commun., 2025,61, 3371-3374

ROS-responsive poly(β-amino ester) nanoparticles enable targeted delivery of mRNA vaccine to splenic antigen-presenting cells

M. Jiang, L. Yan, L. Zeng, Y. Tang, Z. Zhang, B. Chen, M. Qiu and J. Chen, Chem. Commun., 2025, 61, 3371 DOI: 10.1039/D4CC06064D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements